NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com
Research analysts at StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “hold” rating on the stock. NovaBay Pharmaceuticals Trading Up 8.1 % Shares of NYSE:NBY opened at $0.53 on Thursday. The firm has a 50 day moving average […]
